Clinical Study of Multimodal Ablation Remodeling Immunosensitized PD-1 in the Treatment of Pancreatic Cancer With Liver Metastasis

NARecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 8, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Pancreatic Cancer
Interventions
DEVICE

Multi-mode thermal ablation device

The tumor tissue was rapidly frozen until the ice ball exceeded 5mm of the lesion tissue, kept for 5 minutes, then thawed and warmed. Then, complete ablation was performed according to the radiofrequency temperature control mode of multimodal tumor therapy to ensure that the ablation area included a safe range of 5\~10mm around the tumor.

DRUG

Intravenous anti-PD-1 and chemotherapy

intravenous anti-PD-1 and chemotherapy

Trial Locations (1)

200040

RECRUITING

Shanghai General Hospital, Shanghai

All Listed Sponsors
lead

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

OTHER